Janet B. Mcgill - Publications

Impact of Pharmacy Benefit Manager Organizations on Diabetes Management.

Journal: Journal of diabetes science and technology

Published: August 27, 2026

American Association of Clinical Endocrinology Consensus Statement: Use of Diabetes Technology for Management of Adults with Diabetes.

Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Published: June 05, 2026

Safety and Synergy of Finerenone and Empagliflozin in Lowering Blood Pressure.

Journal: Hypertension (Dallas, Tex. : 1979)

Published: June 05, 2026

Finerenone in Type 1 Diabetes and Chronic Kidney Disease. Reply.

Journal: The New England journal of medicine

Published: June 03, 2026

Effect of Finerenone on Albuminuria in Type 1 Diabetes by Baseline HbA1c Level and Diabetes Duration: An Exploratory Analysis of the FINE-ONE Trial.

Journal: Diabetes care

Published: April 14, 2026

Sexual Dimorphism and Age Effects in CKD and Type 2 Diabetes in the CONFIDENCE Trial.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: March 27, 2026

Finerenone in Type 1 Diabetes and Chronic Kidney Disease.

Journal: The New England journal of medicine

Published: March 04, 2026

Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Albuminuria Irrespective of Baseline HbA1c Levels: A Participant-Level Exploratory Analysis of the Randomised CONFIDENCE Trial.

Journal: Diabetes, obesity & metabolism

Published: February 23, 2026

Pulmonary Safety and Clinical Considerations for Inhaled Insulin: A Comprehensive Review.

Journal: Diabetes technology & therapeutics

Published: February 01, 2026

Clinical Impact of Continuous Glucose Monitoring in Noninsulin Treated Type 2 Diabetes: A Review.

Journal: Diabetes technology & therapeutics

Published: January 23, 2026

Acute eGFR Changes and Their Mediation of Albuminuria Reduction with Empagliflozin and Finerenone.

Journal: Journal of the American Society of Nephrology : JASN

Published: January 14, 2026

The Importance of Expanding Medicare Continuous Glucose Monitoring Coverage for High-Risk Hypoglycemia.

Journal: Diabetes technology & therapeutics

Published: November 21, 2025